GI-MAP Interpretation Guide: How to Read Your Results and Understand Each Marker

106 biomarkers Sample: Stool Peer-reviewed

Biomarkers in this category

106 biomarkers · optimal ranges shown

Adenovirus serotypes 40 and 41 cause acute gastroenteritis (inflammation of the stomach and intestines) primarily in children.

Akkermansia muciniphila may represent 3–5% of the microbial composition in the healthy human intestinal tract.

Ascaris lumbricoides is the "large roundworm" of humans, growing to a length of up to 35 cm (14 in). The diagnosis of ascariasis is usually made via stool microscopy.

Microbial enzyme reflecting gut detoxification and microbiome metabolic activity.

Bacillus spp. are spore forming bacteria, ubiquitous in the environment. B. cereus in particular is a frequently recognized cause of toxin-induced acute gastroenteritis.

Bacteroidetes dominates in slimmer people.

Campylobacter is an infectious disease caused by Campylobacter bacteria.

Commensal fungi that can be pathogenic to immunocompromised patients.

Epidemiology: Fecal contamination of food or water Clinical Implications: - Considered non-pathogenic and may not cause symptoms - May indicate dysbiosis or suppressed immunity Therapeutic Options and Considerations: - Look for and address sources of fecal-oral contamination - Consider probiotics and 5R Protocol - Address other imbalances on the GI-MAP What is the 5R Protocol? The 5R Protocol is a widely accepted clinical guideline to treating pathogens and imbalances in the GI microbiota and restoring health to the gastrointestinal tract. Re-test in 3–6 months to monitor progress and make changes to the treatment protocol as needed. To read more about the 5R protocol, please read our 5R protocol blog entry about it.

Prominent and diverse group of bacteria in the microbiome of the large intestine.

E. coli O157:H7 is a foodborne pathogen that causes food poisoning.

Enterobacter are gram-negative bacteria that are classified as facultative anaerobes, which means that they are able to thrive in both aerobic and anaerobic environments. Enterobacter in the human microbiota is a pathogenic (=disease-causing) organism or is capable of becoming pathogenic. Studies have found specific bacteria such as Enterobacter aerogenes are sensitive to melatonin rhythms. As melatonin is secreted from the gut lining, it can cause an increase in Enterobacter aerogenes. This suggests our circadian rhythms may be regulated more closely alongside specific bacterial clocks than we previously realized. [L] References: – https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0146643 – https://www.ncbi.nlm.nih.gov/pubmed/26751389 – https://www.sciencedirect.com/topics/medicine-and-dentistry/enterobacteriaceae – https://www.sciencedaily.com/releases/2018/05/180531102753.htm – https://www.nature.com/articles/ismej2012153

Gram-positive genus of lactate-producing bacteria in the Firmicutes phylum.

bacterial phyla that dominate the entire human digestive tract

Helicobacter pylori has been evolving with human beings for well over 50,000 years, since they migrated out of Africa. H. pylori colonization has been implicated in a variety of gastroduodenal diseases including: - gastritis, - gastric cancer, - and duodenal and peptic ulcer. H. pylori has also been detected by stool PCR in cases of: - dyspepsia, - abdominal pain, - and chronic gastrointestinal symptoms. It is infamous for its causal link to ulcers and gastric cancer, which resulted in a Nobel prize awarded to Robin Warren and Barry Marshall in 2005. However, some sources are suggesting its role, at least in part, as a commensal organism. H. pylori may protect its host from certain atopic disorders, as well as other diseases such as: - esophageal cancer reflux, - and obesity. Population data shows that H. pylori virulence varies geographically. It is associated with high rates of cancer in certain regions, but not in others. The difference may lie in H. pylori’s genetics. Host immune status and acid secretion seem to be other important factors contributing to H. pylori’s colonization and pathogenesis. The H. pylori virulence factors that are most well recognized are vacA and cagA. The presence of cagA-positive H.pylori strains has been significantly associated with gastric cancer and peptic ulcer. The gene codes for a type IV secretion system which allows the bacterium to inject the cagA protein into the host cell. Once inside the host’s gastric epithelial cells, cagA can disrupt cell signaling, leading to abnormal proliferation, motility, and changes in the cytoskeleton. These changes to normal cell signaling can initiate cancer. The presence of vacA has been associated with gastric cancer, peptic ulcer, and duodenal ulcer. The vacA gene is present in all strains of H.pylori but is polymorphic, which leads to different levels of vacuolating toxin. VacA toxins interact with certain receptors on host cells, setting off a chain of events including mitochondrial damage, inhibition of T-lymphocytes, and interference of antigen presentation. Numerous papers suggest the clinical utility of PCR testing for H. pylori. Detection of H.pylori in biopsy specimens by PCR has proven superior to other methods. It has shown sensitivity and specificity reaching that of the diagnostic “gold standard,” which is endoscopy with biopsy and urease test. H.pylori genotyping may be useful for resistant H. pylori infections that have failed to respond to triple antibiotic therapy. In one study of RT-PCR, authors stated it was a “highly accurate noninvasive method to detect H. pylori infection in stool and at the same time allows for culture-independent clarithromycin susceptibility testing.” H. pylori may be asymptomatic and require no treatment or only supportive care to improve the intestinal mucosa and gastrointestinal lining. Information on the cagA and vacA genes may help determine whether treating a positive H. pylori result is necessary.

Mucosal immune antibody measuring gut immune defense activity in stool.

a protein that opens intercellular tight junctions in the gut lining